Publications by authors named "Domi Zhou-Clark"
Article Synopsis
- The FDA has approved lecanemab for early-stage Alzheimer's disease, marking a significant advancement in treating neurodegenerative conditions but also presenting various challenges for healthcare institutions.
- There is a lack of resources for institutions to effectively establish and manage a lecanemab treatment program, prompting the need for a structured framework.
- The report outlines a three-stage implementation study (feasibility assessment, operations, and monitoring), concluding that lecanemab's clinical integration is feasible with proper project management, financial sustainability analysis, and efficient electronic record tools.
